Roche's Latest Analytic Units: The Future of Laboratory Efficiency Gains FDA Clearance Roche has achieved FDA 510(k) clearance for its advanced analytical units, cobas® c 703 and cobas® ISE neo, enhancing laboratory testing efficiency and capacity.

Roche's Latest Analytic Units: The Future of Laboratory Efficiency Gains FDA Clearance #United_States #Indianapolis #Roche_Diagnostics #cobas_c703 #cobas_ISE_neo

Roche's New Respiratory Pathogen Test Enhances Treatment Speed for Patients in Critical Need Roche introduces the cobas eplex RP3, a rapid test for detecting respiratory pathogens, aiding timely treatment decisions for infected patients.

Roche's New Respiratory Pathogen Test Enhances Treatment Speed for Patients in Critical Need #USA #Pleasanton #Roche_Diagnostics #cobas_eplex #respiratory_pathogens

Roche Enhances Mass Spectrometry with New Steroid Assays for Clinical Use Roche's Ionify® steroid assays have gained CLIA 'moderate complexity' approval, simplifying mass spectrometry for routine clinical laboratories and enhancing diagnostic access.

Roche Enhances Mass Spectrometry with New Steroid Assays for Clinical Use #United_States #Indianapolis #Roche_Diagnostics #Ionify_Assays #Cobas_Mass_Spec

Roche Launches Advanced cobas 6800/8800 Systems to Boost Laboratory Efficiency Roche unveils next-gen cobas 6800/8800 systems enhancing laboratory operations. This modernized platform promises significant gains in efficiency and testing capabilities.

Roche Launches Advanced cobas 6800/8800 Systems to Boost Laboratory Efficiency #United_States #Indianapolis #Roche_Diagnostics #cobas_6800 #cobas_8800

Roche's New FDA-Approved Tests Enhance HER2 Breast Cancer Diagnostics for ENHERTU Treatment Roche's PATHWAY HER2 and VENTANA HER2 tests have received FDA approval to identify patients with HER2-positive metastatic breast cancer eligible for ENHERTU treatment.

Roche's New FDA-Approved Tests Enhance HER2 Breast Cancer Diagnostics for ENHERTU Treatment #United_States #Tucson #HER2-positive #Roche_Diagnostics #ENHERTU

Roche's Elecsys pTau181: A New Blood Test for Alzheimer's Detection Roche introduces Elecsys pTau181, the first FDA-cleared blood test for Alzheimer's diagnosis in primary care, enhancing early detection.

Roche's Elecsys pTau181: A New Blood Test for Alzheimer's Detection #United_States #Indianapolis #Roche_Diagnostics #Alzheimer's_Test #Elecsys_pTau181

Roche Achieves CE IVDR Approval for Groundbreaking HER2 Diagnostic Test in Cancer Treatment Roche has proudly announced CE IVDR approval for the VENTANA HER2 (4B5) test, a significant advancement in identifying metastatic breast cancer and biliary tract cancer patients eligible for targeted therapies.

Roche Achieves CE IVDR Approval for Groundbreaking HER2 Diagnostic Test in Cancer Treatment #USA #Tucson #biliary_tract_cancer #Roche_Diagnostics #HER2_Test

Roche Achieves CE IVDR Approval for Revolutionary HER2 Diagnostic Test in Cancer Treatment Roche has secured CE IVDR approval for the VENTANA HER2 (4B5) test, facilitating precise identification of breast and biliary tract cancers, incorporating personalized treatment options.

Roche Achieves CE IVDR Approval for Revolutionary HER2 Diagnostic Test in Cancer Treatment #USA #Cancer_Treatment #Tucson #Roche_Diagnostics #VENTANA_HER2

The Rising Digital Pathology Market: Projected 7.8% Growth by 2032 Explore the expanding digital pathology market projected to grow at a CAGR of 7.8%, driven by innovations in diagnostics and AI technology.

The Rising Digital Pathology Market: Projected 7.8% Growth by 2032 #USA #AI_Integration #Digital_Pathology #Roche_Diagnostics #Westford

Roche Diagnostics Unveils Innovative Leadership in Healthcare at ADLM 2025 Discover Roche's commitment to diagnostic innovation at ADLM 2025, showcasing AI-driven solutions, patient care advancements, and dynamic workshops.

Roche Diagnostics Unveils Innovative Leadership in Healthcare at ADLM 2025 #United_States #Chicago #Roche_Diagnostics #cobas #navify_digital_solutions

Roche's $550 Million Initiative to Boost Diagnostics Manufacturing in Indianapolis by 2030 Roche has announced a significant $550 million investment in its Indianapolis facility aimed at bolstering diagnostics manufacturing and creating jobs by 2030.

Roche's $550 Million Initiative to Boost Diagnostics Manufacturing in Indianapolis by 2030 #United_States #Indianapolis #Roche_Diagnostics #Continuous_Glucose_Monitoring

Nordic Bioscience Launches PRO-C3 Test on Roche Diagnostics Cobas Analyzers Revolutionizing Liver Fibrosis Assessment Nordic Bioscience has debuted its innovative PRO-C3 test in collaboration with Roche Diagnostics, enhancing liver fibrosis evaluation using advanced analyzers.

Nordic Bioscience Launches PRO-C3 Test on Roche Diagnostics Cobas Analyzers Revolutionizing Liver Fibrosis Assessment #Denmark #Roche_Diagnostics #Nordic_Bioscience #PRO-C3 #Herlev

Nordic Bioscience Partners with Roche to Launch PRO-C3 on cobas Analyzers Nordic Bioscience announces the introduction of PRO-C3 test by Roche Diagnostics on cobas analyzers, enhancing liver fibrosis assessment globally.

Nordic Bioscience Partners with Roche to Launch PRO-C3 on cobas Analyzers #Denmark #Roche_Diagnostics #Nordic_Bioscience #PRO-C3 #Herlev

Nordic Bioscience Launches Elecsys PRO-C3 Test Through Roche Diagnostics Nordic Bioscience proudly announces the global launch of the Elecsys PRO-C3 test by Roche Diagnostics for assessing liver fibrosis severity.

Nordic Bioscience Launches Elecsys PRO-C3 Test Through Roche Diagnostics #Denmark #Roche_Diagnostics #Nordic_Bioscience #PRO-C3 #Herlev

Nordic Bioscience Introduces Innovative PRO-C3 Test with Roche Diagnostics for Liver Health Nordic Bioscience announces the launch of their groundbreaking PRO-C3 test in collaboration with Roche Diagnostics, revolutionizing liver health assessment.

Nordic Bioscience Introduces Innovative PRO-C3 Test with Roche Diagnostics for Liver Health #Denmark #Roche_Diagnostics #Nordic_Bioscience #PRO-C3 #Herlev

Nordic Bioscience's Innovative PRO-C3 Test Now Available Through Roche Diagnostics Nordic Bioscience has announced the launch of its PRO-C3 test, now available through Roche Diagnostics on their advanced cobas analyzers, enhancing liver fibrosis assessment.

Nordic Bioscience's Innovative PRO-C3 Test Now Available Through Roche Diagnostics #Denmark #Roche_Diagnostics #Nordic_Bioscience #PRO-C3 #Herlev

Roche's New Test for Preeclampsia: A Game Changer in Maternal Health Monitoring Roche's Elecsys sFlt-1/PlGF ratio test has received FDA approval, providing a reliable method to identify risks of severe preeclampsia in pregnant women.

Roche's New Test for Preeclampsia: A Game Changer in Maternal Health Monitoring #USA #Indianapolis #Roche_Diagnostics #sFlt-1/PlGF #preeclampsia

Roche's Revolutionary Blood Test for Lp(a) Gets FDA Approval in the U.S. Roche Diagnostics has achieved FDA 510(k) clearance for the first-ever blood test in the U.S. to measure Lp(a) levels effectively, enhancing cardiovascular risk assessment.

Roche's Revolutionary Blood Test for Lp(a) Gets FDA Approval in the U.S. #United_States #Indianapolis #FDA_Clearance #Roche_Diagnostics #Lp(a)

Michele Pedrocchi Takes Helm as Chair of Kinomica's Board of Directors Kinomica Ltd. welcomes Michele Pedrocchi, former Roche Diagnostics leader, as the new Chair. His experience aims to enhance precision oncology diagnostics and business growth.

Michele Pedrocchi Takes Helm as Chair of Kinomica's Board of Directors #London #United_Kingdom #Roche_Diagnostics #Kinomica #Michele_Pedrocchi

Roche's FDA Approval for Breakthrough Test in B-cell Lymphoma Diagnosis Roche has received FDA clearance for a pioneering test to accurately diagnose B-cell lymphoma, enhancing treatment options for patients.

Roche's FDA Approval for Breakthrough Test in B-cell Lymphoma Diagnosis #United_States #Tucson #FDA_Clearance #B-cell_Lymphoma #Roche_Diagnostics